Literature DB >> 6486324

Surgical management of malignant tumors of the lacrimal gland.

I Janecka, E Housepian, S Trokel, R Rankow, I Jones, F Jakobiec.   

Abstract

Malignant lacrimal gland tumors are rare but serious and life-threatening neoplasms. Patients frequently present with symptoms of less than 1 year duration, often demonstrating rapid change during the 6 months preceding diagnosis. Pain and periorbital sensory changes are also reported by patients. Radiographically, bone destruction is a strong indication of a lacrimal gland malignancy as is ophthalmoplegia. Radical three-dimensional resection utilizing a cranioorbital approach offers the best chance for total tumor removal. Immediate reconstruction with a scalp flap is essential for primary healing, as well as esthetic balance of the orbital region.

Entities:  

Mesh:

Year:  1984        PMID: 6486324     DOI: 10.1016/0002-9610(84)90384-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.

Authors:  David T Tse
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 2.  Epithelial tumors of the lacrimal gland: clinico-pathologic correlation and management.

Authors:  K G Riedel; A Markl; G Hasenfratz; A Kampik; F H Stefani; O E Lund
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

3.  Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.

Authors:  David T Tse; Pasquale W Benedetto; Brian C Tse; William J Feuer
Journal:  Am J Ophthalmol       Date:  2022-04-02       Impact factor: 5.488

4.  Primary adenocarcinoma of the lacrimal gland.

Authors:  Sang-Oon Baek; Yoon-Jae Lee; Suk-Ho Moon; Young-Jin Kim; Young-Joon Jun
Journal:  Arch Plast Surg       Date:  2012-09-12

5.  Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.

Authors:  David T Tse; Andrea L Kossler; William J Feuer; Pasquale W Benedetto
Journal:  Ophthalmology       Date:  2013-04-09       Impact factor: 12.079

6.  Primary malignant neoplasms of the lacrimal gland.

Authors:  J E Wright; G E Rose; A Garner
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

7.  Pleomorphic adenocarcinoma of the lacrimal gland with multiple intracranial and spinal metastases.

Authors:  Jung Yong Ahn; Jong Hee Chang; Se Hoon Kim; Kyu Sung Lee
Journal:  World J Surg Oncol       Date:  2007-03-07       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.